JAMA Neurology· 2024Q1
Fecal Microbiota Transplantation for Treatment of Parkinson Disease
- 108citations
- Q1SCImago
- 2024year
Short summary
A double-blind, placebo-controlled trial (n=45) found that single-dose fecal microbiota transplantation (FMT) was safe but did not significantly improve Parkinson's disease (PD) motor symptoms at 6 months compared to placebo.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Infectious Diseases
Infectious DiseasesMedicine